Study |
Participant group (n) |
Source of participants |
History of diagnosis of SARS‐CoV‐2 infection |
Inclusion criteria for post‐COVID‐19 condition participants |
Pretorius 2022 |
PCC (80) |
Self‐identified participants in South Africa registered in an online registry |
Not reported |
Self‐reported symptoms of PCC, defined as “recurring long‐term symptoms after you have recovered from acute COVID‐19” |
Pretorius 2021 |
PCC (11) |
Source unclear; possibly from self‐identified participants in South Africa registered in an online registry |
Not reported |
Symptoms of PCC and at least 2 months since acute COVID‐19. Unclear if self‐reported or medically diagnosed |
Control (13) |
People attending clinic prior to SARS‐CoV‐2 outbreak |
N/A as prior to SARS‐CoV‐2 outbreak |
‐ |
Kruger 2022 |
PCC (99) |
Self‐identified participants in South Africa registered in an online registry |
Not reported |
Self‐reported symptoms of PCC, defined as “recurring long‐term symptoms after you have recovered from acute COVID‐19” |
Control (29) |
Described as "volunteers" recruited via a clinical practice |
Not reported |
‐ |
Laubscher 2023 |
PCC (91) |
Described as "volunteers" recruited via a clinical practice |
Not reported |
Diagnosed based on symptoms and clinical examination. Methods not clearly described. |
Turner 2023 |
PCC (40) |
Self‐identified participants in South Africa registered in an online registry |
Not reported |
Self‐reported symptoms of PCC, defined as “recurring long‐term symptoms after you have recovered from acute COVID‐19” |
Control (20) |
Described as "volunteers" recruited via a clinical practice |
Not reported |
‐ |
Abbreviations: N/A: not applicable; PCC: post‐COVID‐19 condition |